Ethosuximide Capsule
Product Images NDC 64380-878

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ethosuximide (NDC 64380-878). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0e9ecd7e 2ba1 499d 84b9 11ded1e3a8bb 01

Chemical structure of ethosuximide, showing its molecular framework with a succinimide ring and ethyl and methyl side groups. The image depicts the active ingredient ethosuximide's chemical composition as registered for pharmaceutical use.*

FDA Label Image

0e9ecd7e 2ba1 499d 84b9 11ded1e3a8bb 02

Label for Ethosuximide Capsules, USP 250 mg by Strides Pharma Science Limited. The label shows dosage form as capsules and package size of 100 capsules. It includes storage instructions, pharmacist dispensing note, and distributor information. The NDC 64380-878-06 is visible with barcodes. The label also displays manufacturer and distributor addresses and revision date 12/2021.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.